BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 27, 2026
See today's BioWorld
Home
» Aiming To Enter Clinic In 2005, BioRexis Gets $30M In Series B
To read the full story,
subscribe
or
sign in
.
Aiming To Enter Clinic In 2005, BioRexis Gets $30M In Series B
March 12, 2004
By
Karen Carey
BioRexis Pharmaceutical Corp. attracted new and existing investors with its protein and peptide drug research, raising $30 million in an oversubscribed Series B round. (BioWorld Today)
BioWorld
